February 5, 2016 / 7:52 AM / 4 years ago

China Resources Pharmaceutical plans HK IPO worth at least $1 bln-IFR

HONG KONG, Feb 5 (Reuters) - China Resources Pharmaceutical Group, a unit of state-owned conglomerate China Resources (Holdings) Co Ltd., plans a Hong Kong initial public offering of at least $1 billion, IFR reported on Friday, citing people close to the deal.

CR Pharma, as the company is called, has sent a request for proposals to banks seeking a role in the deal, with a deadline of Feb. 16 for banks to respond, added IFR, a Thomson Reuters publication.

CR Pharma didn’t immediately reply to a Reuters request for comment on the listing plans. (Reporting by Fiona Lau of IFR; Writing by Elzio Barreto; Editing by Muralikumar Anantharaman)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below